Association between Serum Uric Acid to HDL-Cholesterol Ratio and Nonalcoholic Fatty Liver Disease in Lean Chinese Adults
Table 1
Clinical characteristics of the study population according to NAFLD categories.
Variables
Controls (n = 5631)
NAFLD (n = 654)
t value
value
Gender (male/female)
2080/3551
380/274
110.195a
<0.001
Age (year)
44.53 (12.73)
50.73 (10.97)
11.964
<0.001
Body mass index (kg/m2)
21.19 (1.80)
22.71 (1.05)
21.163
<0.001
Waist circumference (cm)
76.18 (6.79)
82.93 (5.77)
22.991
<0.001
Systolic blood pressure (mmHg)
117.17 (16.75)
127.56 (16.76)
15.021
<0.001
Diastolic blood pressure (mmHg)
71.06 (10.78)
78.13 (10.52)
15.916
<0.001
γ-Glutamyl transpeptidase (U/L)
14.00 (11.00–21.00
26.00 (17.00–39.00)
20.927b
<0.001
Triglyceride (mg/dl)
85.00 (62.87–117.76)
148.76 (106.25–203.21)
24.390b
<0.001
Total cholesterol (mg/dl)
174.04 (32.88)
184.07 (36.24)
7.301
<0.001
HDL-cholesterol (mg/dl)
52.99 (13.10)
43.41 (10.36)
18.045
<0.001
Fasting blood glucose (mg/dl)
87.22 (12.95)
97.03 (23.42)
16.494
<0.001
Serum uric acid (mg/dl)
4.93 (1.21)
5.80 (1.34)
17.088
<0.001
UHR (%)
10.08 (4.22)
14.25 (5.33)
23.226
<0.001
Data are expressed as mean (standard deviation) or median (interquartile range). aχ2 value; bZ value; HDL, high-density lipoprotein; NAFLD, nonalcoholic fatty liver disease; UHR, uric acid to HDL-cholesterol ratio.
